CSG stock comes into this earnings print on a tear, with a 30.2% gain over the past month and a price of €17.71 that still sits far below many analysts’ fair value models. The headline today is simple: CSG turned in a solid Q2 with €1.71b in revenue and €272m in net income, while the trailing twelve month figures continue to support a story of strong profitability.
The market is trading the latest quarter. The real question for investors is how this defence supplier’s multi year backlog, margin ambitions and cash generation stack up against that fast rising share price.
Is CSG trading at a rare discount, or does this low P/E hide quality of earnings and cash flow issues that justify the gap to peers? See how the current price lines up against our valuation analysis for CSG.
Tired of scrolling through walls of earnings figures and defence contract details trying to piece CSG’s story together on your own? Get a clear, visual view of CSG’s valuation and how the market is pricing its profit profile in the company report for CSG.
Bulls argue CSG is a high quality, vertically integrated defence supplier with strong revenue visibility, rising margins and healthy cash generation. The latest half year numbers give that story real backing. Revenue sits at €3.3b with operating EBIT of €784m and a 24.1% margin. Defence Systems carries roughly a 29% margin and Land Systems now accounts for around half of the order backlog. That fits the claim of a higher value mix and an integrated solutions focus.
The record €46b combined backlog and pipeline, with a book to bill of about 1.5x, directly supports the idea of long term visibility. Cash conversion of roughly 80% to 86% and net leverage at 1.6x, with refinanced investment grade debt, also line up with the argument that CSG can fund its U.S. and European expansion from internal cash generation and moderate balance sheet risk.
The main bear arguments target CSG’s contract dependence, working capital strain and founder control. This report shows some of those pressure points but also signs of mitigation. Net working capital is high at 40% of trailing revenue after a deliberate inventory build. Bears will focus on execution risk if that stock is not turned into cash quickly, even though management guides to below 20% by year end.
Customer and country concentration risk is partially addressed. Europe excluding Ukraine is now more than 50% of revenue and the U.S. has become the second largest market. That points to a broader base of government buyers. Governance concerns around control persist, but the board is adding senior leaders from large defence contractors and has secured a single unsecured investment grade facility of €3.06b, which suggests external lenders are comfortable with current risk levels.
Compare CSG’s backlog strength and margin ambitions with how the market thinks those cash flows are worth pricing. See the consensus price target analysis for CSG to check whether analysts think the recent run in ENXTAM:CSG still leaves meaningful upside or has already priced in the good news.If CSG’s backlog strength and margin profile have your attention, register for free with Simply Wall St and add it to your Watchlist so you can track the share price against fair value and watch for a more attractive entry point. Once you own CSG or other stocks, use the Portfolio Command Center to cut through the noise and focus on the key developments that matter to your holdings. For a longer term edge, tap into crowd insights through the Community and see how other investors are thinking about the same risks and catalysts. This way you can spot potential turning points earlier and stay a step ahead of the market.
Fresh ideas can move fast. Some stocks build quiet momentum while others are already flying before the crowd spots them. Check these curated lists while it matters and get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com